- Rating
- 1
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 1
Read review
Paper summary
This paper proposes TRACE, a framework for SEEG seizure detection and onset-time estimation without target-domain tuning. Each channel of a 60 s clip is described by 23 hand-crafted features measuring change relative to the clip's first 8 s, which serve as the episode's background. An XGBoost ensemble maps these features to a channel × time evidence field. A detection branch summarizes the field to decide whether a seizure is present, and an onset branch pools the top channels at each time point and backtracks from sustained high evidence to estimate the onset. Trained on SWEC-ETHZ and HUP and applied zero-shot to Pennsieve-530, TRACE outperforms the strongest of eight baselines in both onset error (oracle MAE 4.80 s vs. 8.89 s) and detection AUROC (0.913 vs. 0.829). Normalization control experiments suggest that the episode-local reference is the main source of this gain.
Critical strengths
- The framework is simple and computationally inexpensive, which keeps the cost of practical deployment low.
- The approach is zero-shot, with no target-domain tuning. This is a meaningful direction for the medical domain, where heterogeneity across patients and institutions is substantial.
- The results are analyzed through a variety of control experiments and multiple metrics. These include comparisons against alternative normalization schemes and experiments that change the source of the reference.
Critical weaknesses
- The core assumption is guaranteed artificially by the data construction. The method assumes that the first 8 s of every clip are always pre-ictal. This holds only because clips are constructed with the onset placed between 10 and 40 s. In realistic settings, where a clip may begin during or immediately after a seizure, this assumption is unlikely to hold.
- Novelty is limited. The method combines hand-crafted features, conventional ML (XGBoost), and a rule-based decoder, and the extracted features themselves offer little novelty.
- Seizure specificity is not evaluated. Background-contrast features may also respond to non-seizure events such as artifacts, interictal events, and sleep/arousal transitions. However, no evaluation is provided on negatives composed of such events.
- The treatment of heterogeneity is not sufficiently validated. It is unclear whether normalizing amplitude and spectral scale alone is sufficient to address heterogeneity. Subgroup analyses by seizure type, electrode type, and institution are needed.
- The external validation set is small. It contains only 44 seizures from 22 patients, which makes it difficult to assess the reliability of the zero-shot performance. In addition, this cohort had already been evaluated with an earlier configuration, and 19 of its 29 patients come from the same institution as a training cohort (HUP).
Questions for authors
- How does the method perform when the first 8 s contain a seizure or artifacts? How does it perform when applied in a sliding manner to continuous recordings, without the constraint on onset position?
- What is the false positive rate on negative clips composed of artifacts, interictal events, or state transitions?
- How were the weights of the threshold objective (Eq. 12; 5/3/2/2/3) chosen? Also, since the AUROC term does not vary with the threshold, does it not have any effect on the optimization?
- The rationale behind several design choices is unclear, including the 8 s reference, the three-model ensemble, and the 20/80 percentiles. Could the authors explain the specific reasoning behind each choice and provide sensitivity analyses?